<PAGE>
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No. 4)*
ENDOSONICS CORPORATION
- --------------------------------------------------------------------------------
(Name of Issuer)
Common Stock, $.001 Par Value Per Share
- --------------------------------------------------------------------------------
(Title of Class of Securities)
29264k105
- --------------------------------------------------------------------------------
(CUSIP Number)
Gilbert H. Davis, Esq.
SIMS MOSS KLINE & DAVIS LLP
400 Northpark Town Center, Suite 310
1000 Abernathy Road, N.E.
Atlanta, Georgia 30328
(770) 481-7205
- --------------------------------------------------------------------------------
(Name, Address and Telephone Number of Person Authorized to
Receive Notices and Communications)
April 21, 1999
- --------------------------------------------------------------------------------
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to report
the acquisition which is the subject of this Schedule 13D, and is filing this
schedule because of Rule 13d-1(b)(3) or (4), check the following box [ ].
NOTE: Six copies of this statement, including all exhibits, should be filed with
the Commission. See Rule 13d-1(a) for other parties to whom copies are to be
sent.
1
<PAGE>
SCHEDULE 13D
CUSIP No. 29264k105
---------------
- --------------------------------------------------------------------------------
1 NAMES OF REPORTING PERSONS
James O. Patterson
- --------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [ ]
(b) [X]
- --------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------
4 SOURCE OF FUNDS* WC, OO
- --------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS
2(d) or 2(e) [ ]
- --------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION United States
- --------------------------------------------------------------------------------
7 SOLE VOTING POWER 840,000
NUMBER OF
SHARES -----------------------------------------------------------------
BENEFICIALLY 8 SHARED VOTING POWER NONE
OWNED BY
EACH
REPORTING -----------------------------------------------------------------
PERSON 9 SOLE DISPOSITIVE POWER 840,000
WITH
-----------------------------------------------------------------
10 SHARED DISPOSITIVE POWER NONE
- --------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON: 840,000
- --------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES* [ ]
- --------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 4.7%
- --------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON IN
- --------------------------------------------------------------------------------
2
<PAGE>
Pursuant to Rule 13d-2(a) of Regulation 13D-G of the General Rules and
Regulations under the Securities Exchange Act of 1934, as amended (the "Act"),
the undersigned hereby amend their Schedule 13D Statement dated June 19, 1998,
as previously amended pursuant to Amendment No.1 thereto dated July 22, 1998,
Amendment No. 2 thereto dated September 29,1998, and Amendment No. 3 thereto
dated October 21,1998 relating to the common stock, $.001 par value, of
Endosonics Corporation ("Company") (such initial Schedule 13D and the prior
amendments thereto shall hereinafter be referred to as the "Statement"). Unless
otherwise indicated, all defined terms used in this Amendment No. 4 to the
Statement (this "Amendment") shall have the same meanings as those set forth in
the Statement. There has been no material change in the information included in
the Statement except as regards the information contained in Item 5 of the
Statement, which is supplemented as set forth below.
Item 5. Interest in Securities of the Issuer.
------------------------------------
As of April 21, 1999, Phoenix, Falcon Fund and Mustang had purchased shares
of Company stock such that Mr. Patterson's beneficial ownership had been
increased to 840,000 shares, or approximately 4.7% of outstanding shares. Of
those shares, 295,267 (1.7% of outstanding shares) were owned directly by
Phoenix, 302,233 (1.7% of outstanding shares) were owned directly by Falcon Fund
and 242,500 (1.4% of outstanding shares) were owned directly by Mustang.
The percentages of outstanding shares of the Company stock set out in the
preceding paragraph are computed based on a total of 17,760,903 outstanding
shares of Company stock as of March 29, 1999, as indicated by the Company's
Annual Report on Form 10-K for the year ended December 31, 1998.
During the 60 days prior to April 21, 1999, the parties filing the Statement
have engaged in the following transactions in shares of the Company stock:
<TABLE>
<CAPTION>
NO. OF SHARES PRICE
DATE PARTY PURCHASED/(SOLD) PER SHARE
- -------------- ------- ---------------- ---------
<S> <C> <C> <C>
04/09/99 Phoenix (12,348) $5.2500
(30,646) 5.0000
Falcon (12,652) 5.2500
(29,354) 5.0000
Mustang (25,000) 5.2500
(60,000) 5.0625
04/12/99 Phoenix (12,355) 5.0000
Falcon (12,645) 5.0000
Mustang (25,000) 5.0000
(5,000) 5.0000
04/13/99 Phoenix (2,396) 4.6875
Falcon (2,604) 4.6875
Mustang (5,000) 4.6875
04/19/99 Phoenix (18,420) 5.1667
Falcon (19,080) 5.1667
Mustang (37,500) 5.1667
4/20/99 Phoenix (12,351) 5.1250
(18,526) 5.0792
Falcon (12,649) 5.1250
(18,974) 5.0792
Mustang (25,000) 5.1250
(37,500) 5.0792
</TABLE>
3
<PAGE>
NO. OF SHARES PRICE
DATE PARTY PURCHASED/(SOLD) PER SHARE
- -------------- ------- --------------- ---------
4/21/99 Phoenix (12,351) $ 5.00
(6,175) 5.00
Falcon (12,649) 5.00
(6,325) 5.00
Mustang (25,000) 5.00
(12,500) 5.00
Each of the above transactions was effected on the open market through the
National Association of Securities Dealers, Inc. Automated Quotation Systems
(Nasdaq).
Signatures
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
Date: April 22, 1999 /s/ James O. Patterson
----------------------------------------------
James O. Patterson
PHOENIX
Date: April 22, 1999 By: /s/ James O. Patterson
------------------------------------------
James O. Patterson, Managing
General Partner
FALCON FUND INTERNATIONAL
PARTNERSHIP
By: Falcon Fund, Investment
General Partner
By: J.O. Patterson & Co., General
Partner
Date: April 22, 1999 By: /s/ James O. Patterson
--------------------------------------
James O. Patterson, President
4
